// App-Quantinova.ai

903 : IFN-a induced PD-L1 on tumor and host cells co-operatively prevents tumor immune elimination after cancer immunoediting

Researchers

Presenter

  • Takuro Noguchi

Principal Investigators

  • Jeffrey P. Ward

  • Matthew M. Gubin

  • Cora Arthur

  • Robert D. Schreiber

Medical Centers

  • Washington University in St Louis, St. Louis, MO

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Sarcoma

  • Solid malignancies

Biomarkers

  • Programmed cell death protein 1

Drug/Treatment

  • IFN-lambda

Outcome

  • N/A

Study Design

  • Adaptive

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved